Docosahexaenoic fatty acid nanoencapsulated with Anti-PECAM-1 as strategy to increase atherosclerotic plaque stability
Cardiovascular diseases (CVDs) are the main cause of mortality worldwide, being the ischemic heart disease responsible for 85% of deaths. Atherosclerosis is a chronic inflammation of the arteries that underlies ischemic forms of CVD and involves the innate and adaptive immune systems, from initial fatty ...
Ácidos Docosahexaenoicos/análisis, Nanocápsulas/análisis, Aterosclerosis/patología, Placa Aterosclerótica/metabolismo, Antiinflamatorios/administración & dosificación, Arterias/anomalías, Causalidad, Enfermedades Cardiovasculares/clasificación, Estrategias de Salud, Molécula-1 de Adhesión Celular Endotelial de Plaqueta, Nanopartículas, Preparaciones Farmacéuticas/análisis